Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference
about
Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrateThe microfluidic multitrap nanophysiometer for hematologic cancer cell characterization reveals temporal sensitivity of the calcein-AM efflux assay.Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignanciesDi-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).Application of fluorescent dye substrates for functional characterization of ABC multidrug transporters at a single cell level.A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of ActionHuman ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1Nature and uses of fluorescent dyes for drug transporter studies.A Versatile Cell Death Screening Assay Using Dye-Stained Cells and Multivariate Image AnalysisTPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.Phenotypic drug profiling in droplet microfluidics for better targeting of drug-resistant tumors.Cell-free microfluidic determination of P-glycoprotein interactions with substrates and inhibitors.The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer.The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations.Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery.
P2860
Q28535627-60887ABD-E2F1-4309-92CF-36FC7B3F54C7Q30579248-33D6961F-1DC5-486E-91AD-43648C606457Q34159739-9E7B0181-C5E3-47D4-98A5-1FAB792C4280Q35351758-F424D739-0731-492B-84B5-C296DC33F76FQ36125117-68EDF7E3-1543-4034-9C2E-0AA82A638F30Q37023216-FB5C1347-8816-4DE0-B054-A5528EB3741CQ37218015-89376A77-F26F-4178-8EC5-9C0016B89CACQ38518912-AB4A3C88-0BDE-4F26-882F-E3BD97F8E186Q38831307-23A83336-0B57-46F0-B7A0-1F4FF3CDE0D8Q38842165-DF2D4BDC-4D86-4855-9D0B-BE2F7FFD0B1AQ43147021-8E28A65B-77EE-4644-839B-526305BAAA07Q45181902-36B016C3-EA8D-4755-BBA8-59E4EA64EE7FQ47214772-D3189DDF-BBAD-4305-ACBC-93BCF9EE2680Q48371869-F69C9ADF-0E7C-44BE-9A4D-B690FC198BDDQ50420935-4D10197D-8971-4D51-8C68-EF4A075C6EEA
P2860
Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Screening compounds with a nov ...... tidrug resistance interference
@ast
Screening compounds with a nov ...... tidrug resistance interference
@en
Screening compounds with a nov ...... tidrug resistance interference
@nl
type
label
Screening compounds with a nov ...... tidrug resistance interference
@ast
Screening compounds with a nov ...... tidrug resistance interference
@en
Screening compounds with a nov ...... tidrug resistance interference
@nl
prefLabel
Screening compounds with a nov ...... tidrug resistance interference
@ast
Screening compounds with a nov ...... tidrug resistance interference
@en
Screening compounds with a nov ...... tidrug resistance interference
@nl
P2093
P2860
P1433
P1476
Screening compounds with a nov ...... tidrug resistance interference
@en
P2093
Megan R Ansbro
Stuart H Yuspa
Suneet Shukla
Suresh V Ambudkar
P2860
P304
P356
10.1371/JOURNAL.PONE.0060334
P407
P577
2013-01-01T00:00:00Z